FLUCONAZOL NYCOMED 150MG kõvakapsel Estland - Estlands - Ravimiamet

fluconazol nycomed 150mg kõvakapsel

takeda pharma as - flukonasool - kõvakapsel - 150mg 1tk; 150mg 2tk

LOCARING kõvakapsel Estland - Estlands - Ravimiamet

locaring kõvakapsel

actavis group ptc ehf. - flukonasool - kõvakapsel - 150mg 1tk

MYCOSYST 150 MG kõvakapsel Estland - Estlands - Ravimiamet

mycosyst 150 mg kõvakapsel

gedeon richter plc. - flukonasool - kõvakapsel - 150mg 4tk; 150mg 1tk

DIFLAZON kõvakapsel Estland - Estlands - Ravimiamet

diflazon kõvakapsel

krka, d.d., novo mesto - flukonasool - kõvakapsel - 150mg 1tk

DIFLAZON infusioonilahus Estland - Estlands - Ravimiamet

diflazon infusioonilahus

krka, d.d., novo mesto - flukonasool - infusioonilahus - 2mg 1ml 100ml 1tk

DIFLAZON kõvakapsel Estland - Estlands - Ravimiamet

diflazon kõvakapsel

krka, d.d., novo mesto - flukonasool - kõvakapsel - 100mg 28tk

Nubeqa Europese Unie - Estlands - EMA (European Medicines Agency)

nubeqa

bayer ag - darolutamide - prostatic kasvajad, kastreerimine-vastupidavad - endokriinset ravi - nubeqa is indicated for the treatment of adult men with- non metastatic castration resistant prostate cancer (nmcrpc) who are at high risk of developing metastatic disease (see section 5. - metastatic hormone sensitive prostate cancer (mhspc) in combination with docetaxel and androgen deprivation therapy (see section 5.

Hepcludex Europese Unie - Estlands - EMA (European Medicines Agency)

hepcludex

gilead sciences ireland uc - bulevirtide acetate - hepatitis d, chronic - viirusevastased ravimid süsteemseks kasutamiseks - hepcludex is indicated for the treatment of chronic hepatitis delta virus (hdv) infection in plasma (or serum) hdv-rna positive adult patients with compensated liver disease.

Livtencity Europese Unie - Estlands - EMA (European Medicines Agency)

livtencity

takeda pharmaceuticals international ag ireland branch - maribavir - tsütomegaloviiruse infektsioonid - viirusevastased ravimid süsteemseks kasutamiseks - livtencity is indicated for the treatment of cytomegalovirus (cmv) infection and/or disease that are refractory (with or without resistance) to one or more prior therapies, including ganciclovir, valganciclovir, cidofovir or foscarnet in adult patients who have undergone a haematopoietic stem cell transplant (hsct) or solid organ transplant (sot). tuleks arvesse võtta ametlikke juhiseid sobiva kasutamise kohta viirusevastane ained.

Vafseo Europese Unie - Estlands - EMA (European Medicines Agency)

vafseo

akebia europe limited - vadadustat - renal insufficiency, chronic; anemia - antianemilised preparaadid - vafseo is indicated for the treatment of symptomatic anaemia associated with chronic kidney disease (ckd) in adults on chronic maintenance dialysis.